Kelly Bugos MS, ANP-BC is a Director for the Center for Advanced Practice and a nurse practitioner specializing in cancer survivorship at Stanford Health Care. Ms. Bugos is the Director of Professional Development and the Advanced Practice Provider (APP) Fellowship Program. As director, Ms. Bugos focuses on APP leadership development. Opened in 2016, the APP Fellowship Program educates and trains APPs in transition to professional practice and specialty care, like administration and cancer care. She founded the cancer survivorship clinics at Stanford in 2012 and continues to focus her clinical work on helping people touched by cancer restore their health after treatment. Ms. Bugos has developed other professional roles and programs over her career at Stanford, like the nurse practitioner position in the 1990s. She has expertise in leadership of advanced practice providers, complex patient care in the outpatient setting, long term and late effects of cancer and its treatment, including symptom management. She is a frequent speaker and author on these topics at the regional and national level.
- Cancer > Urologic Oncology
- Nurse Practitioner
- Director of Advance Practice
Member, Stanford Cancer Institute
Honors & Awards
Best Abstract in Leadership and Management, Oncology Nursing Society (March, 2019)
Best Poster Abstract, National Nurses Research Conference (June, 2016)
BMT Excellence Award for Outstanding Service, Stanford Blood and Marrow Transplant Program (2007)
Board Certification, American Nurses Credentialing Center, Nurse Professional Development
Board Certification: American Nurses Credentialing Center, Nurse Practitioner (2013)
MS, University of California at San Francisco, Nursing
BS, University of Rochester, Nursing
Highlighting an Advanced Practice Fellowship for Leadership Transition.
The Journal of nursing administration
2023; 53 (3): 181-182
As the advanced practice provider (APP) workforce continues to rapidly grow in healthcare, there is a greater need for APP leadership positions. Often, these positions are organically designated to the best clinicians on the team, who may not have leadership experience. Stanford Health Care Center for Advanced Practice embarked on formalized leadership training using a newly developed administration specialty within the APP Fellowship Program to support new leader transition.
View details for DOI 10.1097/NNA.0000000000001265
View details for PubMedID 36821502
- Post Treatment and Survivorship Care Chemotherapy and Immunotherapy Guidelines Oncology Nursing Society. 2023
IMMEDIATE HYPERGLYCEMIA MANAGEMENT IN THE ONCOLOGY INFUSION CENTER
ONCOLOGY NURSING SOC. 2022
View details for Web of Science ID 000790312800056
Distress Screening Through Patient-Reported Outcomes Measurement Information System (PROMIS) at an Academic Cancer Center and Network Site: Implementation of a Hybrid Model.
JCO oncology practice
Cancer care guidelines recommend regular distress screening of patients, with approximately one in three patients with cancer experiencing significant distress. However, the implementation of such programs is variable and inconsistent. We sought to assess the feasibility of implementing a hybrid electronic and paper screening tool for distress in all patients coming to a large academic cancer center and an associated integrated network site.Patients at an academic cancer center (Stanford Cancer Center) and its associated integrated network site received either an electronic or on-paper modified Patient-Reported Outcomes Measurement Information System-Global Health questionnaire, to assess overall health and distress. We used the Reach, Effectiveness, Adoption, Implementation, and Maintenance implementation framework to test and report on the feasibility of using this questionnaire. Iterative workflow changes were made to implement the questionnaire throughout the healthcare system, including processes to integrate with existing electronic health records.From June 2015 to December 2017, 53,954 questionnaires representing 26,242 patients were collected. Approximately 30% of the questionnaires were completed before the visit on an electronic patient portal. The number of patients meeting the positive screen threshold remained around 40% throughout the study period. Following assessment, there were 3,763 referrals to cancer supportive services. Of note, those with a positive screen were more likely to have a referral to supportive care (odds ratio, 6.4; 95% CI, 5.8 to 6.9; P < .0001).The hybrid electronic and on-paper use of a commonly available patient-reported outcome tool, Patient-Reported Outcomes Measurement Information System-Global Health, as a large-scale distress screening method, is feasible at a large integrated cancer center.
View details for DOI 10.1200/OP.20.00473
View details for PubMedID 33830852
USE OF FELLOWSHIP TO EDUCATE AND TRAIN NEW GRADUATE ADVANCED PRACTICE NURSES IN ONCOLOGY
ONCOLOGY NURSING SOC. 2019
View details for Web of Science ID 000461140000070
- Evidence-Based Survivorship Care: Current and Future Challenges in Survivorship Research. In Haylock, P.J. Cancer Survivorship Oncology Nursing Society . 2019; 1: 3–14
Patient reported symptom severity in cancer survivors.
AMER SOC CLINICAL ONCOLOGY. 2017
View details for Web of Science ID 000443300500134
- Palliative Care Always: Massive Open Online Education to Build Primary Palliative Care in a Global Audience ELSEVIER SCIENCE INC. 2016: E83–E84
- Palliative Care Always as a massive open online course (MOOC) to build primary palliative care in a global audience AMER SOC CLINICAL ONCOLOGY. 2016
VALUE OF ADVANCED PRACTICE PROVIDER (APP) LED TRANSITION TO SURVIVORSHIP VISITS (TSV) AT STANFORD CANCER INSTITUTE (SCI).
ONCOLOGY NURSING SOC. 2015: E147
View details for Web of Science ID 000357901300113
Issues in Adult Blood Cancer Survivors
Seminars in Oncology Nursing
2015; 31 (1): 60-66
To describe the current literature and future directions of survivorship care for the adult blood cancer population including unique features, identification of needs, practice guidelines, care models and the implications for nursing.Peer reviewed literature, government and national advocacy organization reports, professional organization guidelines.Adult blood cancer survivors are a heterogeneous population that often receives complicated treatments to live a longer life. Survivorship needs among this population are often unmet throughout the cancer care continuum. The limited research literature and guidelines point to survivorship care strategies from the day of diagnosis to enhance long-term outcomes and improve quality of life.Nurses are experts in symptom management and central to preventing, detecting, measuring, educating, and treating the effects of cancer and its treatment. Moreover, nurses are key to implementing strategies to support blood cancer survivors, families, and caregivers from the day of diagnosis to the last day of life.
View details for DOI 10.1016/j.soncn.2014.11.007
Health behaviors and needs of melanoma survivors
SUPPORTIVE CARE IN CANCER
2014; 22 (11): 2973-2980
Little is known about melanoma survivors' long-term symptoms, sun protection practices, and support needs from health providers.Melanoma survivors treated at Stanford Cancer Center from 1995 through 2011 were invited to complete a heath needs survey. We compared responses of survivors by sex, education, time since diagnosis (long-term vs. short-term survivors), and extent of treatment received (wide local excision (WLE) alone versus WLE plus additional surgical or medical treatment (WLE+)).One hundred sixty melanoma survivors (51 % male; 61 % long-term; 73 % WLE+) provided evaluable data. On average, patients were 62 years of age (SD = 14), highly educated (75 % college degree), and Caucasian (94 %). Overall, participants rated anxiety as the most prevalent symptom (34 %). Seventy percent reported that their health provider did not address their symptoms, and 53 % requested education about melanoma-specific issues. Following treatment, women spent significantly less time seeking a tan compared with men (p = 0.01), had more extremity swelling (p = 0.014), and expressed higher need for additional services (p = 0.03). Long-term survivors decreased their use of tanning beds (p = 0.03) and time spent seeking a tan (p = 0.002) and were less likely to receive skin screening every 3-6 months (p < 0.001) compared with short-term survivors. WLE+ survivors reported greater physical long-term effects than WLE survivors (p ≤ 0.001) following treatment.Melanoma survivors experience continuing symptoms long after treatment, namely anxiety, and they express a need for information about long-term melanoma effects, psychosocial support, and prevention of further skin cancer.
View details for DOI 10.1007/s00520-014-2286-0
View details for Web of Science ID 000343053700012
Health behaviors and survivorship needs of short-versus long-term melanoma survivors
AMER SOC CLINICAL ONCOLOGY. 2013
View details for Web of Science ID 000335419602762
Distress screening through PROMIS at an academic cancer center and network site: Implementation of a hybrid model.
AMER SOC CLINICAL ONCOLOGY. 2020
View details for Web of Science ID 000560368301136
Integrating cancer survivorship care into allogeneic BMT recovery.
AMER SOC CLINICAL ONCOLOGY. 2017
View details for Web of Science ID 000443300500037
Survivorship care plan: Use of the 'Oncology History' (OncHx) feature of the Epic electronic health record (EHR).
AMER SOC CLINICAL ONCOLOGY. 2017
View details for Web of Science ID 000443300500047
- Survivorship care plan: Use of the "Oncology History" (OncHx) feature of the Epic electronic health record (EHR). AMER SOC CLINICAL ONCOLOGY. 2014
Melanoma survivor treatment severity and correlates of psychosocial and physical health.
AMER SOC CLINICAL ONCOLOGY. 2013
View details for Web of Science ID 000335419604749
Multiple Myeloma: Supportive Care Requirements and Coordination of Patient-Centered Care
JOURNAL OF MANAGED CARE PHARMACY
2012; 18 (8): S20-S29
View details for Web of Science ID 000311065300004
- Older Adults: The New Face of Transplantation Oncology Nursing Society Blood and Marrow Stem Cell Transplant Special Interest Group Newsletter 2010; 21 (3): 3